PRC1 IS AN ESSENTIAL DEPENDENCY AND THERAPEUTIC TARGET IN SMARCB1 DEFICIENT ATYPICAL TERATOID RHABDOID TUMORS

被引:0
|
作者
Alimova, Irina [1 ,2 ]
Danis, Ettiene [1 ]
Weetall, Marla [3 ]
Pierce, Angelela M. [1 ,2 ]
Balakrishnan, Ilango [1 ]
Wang, Dong [1 ]
Foreman, Nicholas K. [1 ,2 ,4 ]
Baird, John [3 ]
Hoffman, Lindsey [1 ,2 ]
Venkataraman, Sujatha [1 ,2 ]
Vibhakar, Rajeev [1 ,2 ,4 ]
机构
[1] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO USA
[2] Childrens Hosp Colorado, Morgan Adams Fdn Pediat Brain Tumor Res Program, Aurora, CO USA
[3] PTC Therapeut Inc, South Plainfield, NJ USA
[4] Univ Colorado, Dept Neurosurg, Aurora, CO USA
关键词
D O I
10.1093/neuonc/noz036.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ATRT-05
引用
收藏
页码:63 / 64
页数:2
相关论文
共 50 条
  • [21] NQO1 as a therapeutic target for atypical teratoid/rhabdoid tumor
    Meade, Julia C.
    Moore, Zachary R.
    Stuart, Sarai H.
    Cholka, Agnieszka
    Boriack, Richard L.
    Xu, Jingying
    Erdreich-Epstein, Anat
    Rakheja, Dinesh
    Boothman, David A.
    Amatruda, James F.
    Laetsch, Theodore W.
    CANCER RESEARCH, 2016, 76
  • [22] HIPPO SIGNALING IS ESSENTIAL FOR THE PHENOTYPE ASSOCIATED WITH snr1 LOSS IN DROSOPHILA MELANOGASTER AND INVOLVED IN THE BIOLOGY OF SMARCB1-DEFICIENT ATYPICAL TERATOID/RHABDOID TUMORS
    Hasselblatt, Martin
    Jeibmann, Astrid
    Eikmeier, Kristin
    Linge, Anna
    Johann, Pascal
    Koos, Bjorn
    Bartelheim, Kerstin
    Kool, Marcel
    Pfister, Stefan M.
    Fruehwald, Michael C.
    Paulus, Werner
    NEURO-ONCOLOGY, 2014, 16 : 3 - 4
  • [23] SMARCB1 loss induces druggable cyclinD1deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors
    Xue, Yibo
    Zhu, Xianbing
    Meehan, Brian
    Venneti, Sriram
    Martinez, Daniel
    Morin, Genevieve
    Maiga, Rayelle, I
    Chen, Hongbo
    Papadakis, Andreas, I
    Johnson, Radia M.
    O'Sullivan, Maureen J.
    Erdreich-Epstein, Anat
    Gotlieb, Walter H.
    Park, Morag
    Judkins, Alexander R.
    Pelletier, Jerry
    Foulkes, William D.
    Rak, Janusz
    Huang, Sidong
    JOURNAL OF PATHOLOGY, 2020, 252 (01): : 77 - 87
  • [24] Spatial and temporal conditions for Smarcb1 deletion determines mouse AT/RT (atypical teratoid/rhabdoid tumor) subtype
    Han, Zhi-Yan
    Andrianteranagna, Mamy
    Jesus-Lobon-Iglesias, Maria
    Tauziede-Espariat, Arnault
    Beccaria, Kevin
    Freneaux, Paul
    Waterfall, Joshua J.
    Masliah-Planchon, Julien
    Bourneix, Christine
    Pierron, Gaelle
    Leruste, Amaury
    Chauvin, Celine
    Surdez, Didier
    Varlet, Pascale
    Dufour, Christelle
    Delattre, Olivier
    Dangouloff-Ros, Volodia
    Bourdeaut, Franck
    CANCER RESEARCH, 2020, 80 (14) : 113 - 113
  • [25] VALIDATION OF PROTEASOME INHIBITION AS A THERAPEUTIC TARGET IN ATYPICAL TERATOID/RHABDOID TUMORS
    Morin, Andrew
    Soane, Caroline
    Pierce, Angela
    Alimova, Irina
    Desmarais, Michele
    Zahedi, Shadi
    Vibhakar, Rajeev
    Griesinger, Andrea
    Green, Adam
    Hoffman, Lindsey
    Levy, Jean Mulcahy
    NEURO-ONCOLOGY, 2018, 20 : 31 - 31
  • [26] High Prevalence of SMARCB1 Germline Abnormality in Rhabdoid Tumors
    Shirai, R.
    Osumi, T.
    Uchiyama, M.
    Tsujimoto, S.
    Yoshida, M.
    Uchiyama, T.
    Tomizawa, D.
    Watanabe, K.
    Shioda, Y.
    Kiyotani, C.
    Terashima, K.
    Yoshioka, T.
    Ogawa, S.
    Matsumoto, K.
    Kato, M.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S649 - S650
  • [27] SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors
    Smith, Miriam J.
    Wallace, Andrew J.
    Bowers, Naomi L.
    Eaton, Helen
    Evans, D. Gareth R.
    CANCER GENETICS, 2014, 207 (09) : 373 - 378
  • [28] Uncommon Focal/Regional Heterozygous or Homozygous Deletion of SMARCB1 (hSNF5/INI1) Locus in Two Atypical Teratoid/Rhabdoid Tumors
    Peterson, J. E. G.
    Mehta, V.
    Mohila, C. A.
    Adesina, A. M.
    MODERN PATHOLOGY, 2013, 26 : 417A - 417A
  • [29] Uncommon Focal/Regional Heterozygous or Homozygous Deletion of SMARCB1 (hSNF5/INI1) Locus in Two Atypical Teratoid/Rhabdoid Tumors
    Peterson, J. E. G.
    Mehta, V.
    Mohila, C. A.
    Adesina, A. M.
    LABORATORY INVESTIGATION, 2013, 93 : 417A - 417A
  • [30] Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)
    Bookhout, Christine
    Bouldin, Thomas W.
    Ellison, David W.
    NEUROPATHOLOGY, 2018, 38 (03) : 305 - 308